CAM
CELG

Concorde Asset Management’s Celgene Corp CELG Stock Holding History

Concorde Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,980
Closed -$491K – 151
2016
Q2 		$491K Hold
4,980
– – 0.49% 49
2016
Q1 		$498K Buy
4,980
+744
+18% +$76.6K 0.57% 45
2015
Q4 		$507K Buy
4,236
+2
+0% +$231 0.56% 43
2015
Q3 		$458K Buy
+4,234
New +$525K 0.78% 40
2015
Q2 		– Sell
-4,678
Closed -$553K – 135
2015
Q1 		$553K Buy
4,678
+478
+11% +$57.1K 0.63% 33
2014
Q4 		$518K Buy
+4,200
New +$443K 0.65% 38

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Concorde Asset Management's CELG Position: Q3 2016 in Review

Concorde Asset Management sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 4,980 shares — an estimated $491K sold.

Concorde Asset Management first reported a position in CELG in Q4 2014 and held it in 6 quarters. The position peaked at $553K in Q1 2015. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Concorde Asset Management reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Concorde Asset Management sold 4,980 Celgene Corp shares in Q3 2016, an estimated $491K.
  • Concorde Asset Management first reported a position in Celgene Corp in Q4 2014 and held it in 6 quarters.
  • Concorde Asset Management's Celgene Corp position peaked at $553K in Q1 2015.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Concorde Asset Management's 13F filing for Q3 2016, filed 31 Oct 2016.